Predictors of high-cost managed care patients with acute coronary syndrome

Current Medical Research and Opinion

Volumn 21, Issue 12, 2005, Pages 1977-1984

  Etemad, Lida R ^a   McCollam, Patrick L ^b  

^a Ingenix Inc   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Angina, unstable; Health expenditures; Health maintenance organization; Myocardial infarction

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DEMOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MANAGED CARE ORGANIZATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CODING; PHARMACY BENEFIT MANAGER; PREDICTION;

ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COHORT STUDIES; CORONARY ARTERY BYPASS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES;

EID: 29144534938     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079905X74970     Document Type: Conference Paper

References (16)

1. Olin GL, Machlin SR. Health care expenses in the community population, 1999. Rockville (MD): Agency for Healthcare Research and Quality; 2003 [MEPS Chartbook No. 11. AHRQ Pub. No. 03-0038]
2. Etemad LR, McCollam PL. Total first year costs of acute coronary syndrome for patients in a managed care setting. J Manag Care Pharm 2005;11(4):300-6
3. Grech ED, Ramsdale DR. ABC of interventional cardiology. Acute coronary syndrome: unstable angina and non-ST segment elevation myocardial infarction. Br Med J 2003;326:1259-61
4. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. New Engl J Med 2001;344:1879-87
5. Wallentin L, Lagerqvist B, Husted S, et al. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary artery disease: the FRISC II invasive randomized trial. Lancet 2000;356:9-16
6. Kozak LJ, Hall MJ, et al. National hospital discharge survey: 2000 annual summary with detailed diagnosis and procedure data [National Center for Health Statistics]. Vital Health Stat 2002;13:153
7. Anderson HV, Shaw RE, Brindis RG, et al. A contemporary overview of percutaneous coronary interventions, The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). J Am Coll Cardiol 2002;39:1096-103
8. Schneeweiss R, Cherkin DC, Hart LG, et al. Diagnosis clusters adapted for ICD-9-CM and CDHPPC-2. J Fam Pract 1986;22:69-72
9. Peterson ED, DeLong ER, Muhlbaier LH, et al. Challenges in comparing risk-adjusted bypass surgery mortality results: results from the Cooperative Cardiovascular Project. J Am Coll Cardiol 2000;36:2174-84
10. Hlatky MA, Boothroyd D, Brooks MM, et al. Clinical correlates of the initial and long-term cost of coronary bypass surgery and coronary angioplasty. Am Heart J 1999;138:376-83
11. Ellis SG, Brown KJ, Ellert R, et al. Cost of cardiac care in the three years after coronary catheterization in a contained care system: critical determinants and implications. J Am Coll Cardiol 1998;31:1306-13
12. Guadagnoli E, Hauptman PJ, Ayanian JZ, et al. Variation in the use of cardiac procedures after acute myocardial infarction. New Engl J Med 1995;333:573-8
13. Cohen DJ, Becker ER, Culler SD, et al. Impact of patient characteristics, complications, and facility volume on the costs and time of cardiac catheterization and coronary angioplasty in 70 catheterization laboratories. Am J Cardiol 2000;86:595-601
14. McCollam PL, Etemad LR. Cost of care for new onset acute coronary syndrome patients who undergo coronary revascularization. J Invasive Cardiol 2005;17:307-11
15. Mahoney EM, Jurkovitz CT, Chu H, et al. Costs and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction. J Am Med Assoc 2002;288:1851-8
16. Etemad LR, Yu EB, Wanke LA. Dose adjustment over time of etanercept and infliximab in patients with rheumatoid arthritis. Managed Care Interface 2005;18:21-7